Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Opioid-induced constipation in intensive care patients: relief in sight?

    Chappell D, Rehm M, Conzen P.

    Crit Care. 2008;12(4):161. Epub 2008 Jul 1.PMID: 18598388 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Methylnaltrexone for opioid-induced constipation in advanced illness.

    Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.

    N Engl J Med. 2008 May 29;358(22):2332-43.PMID: 18509120 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.

    Shaiova L, Rim F, Friedman D, Jahdi M.

    Palliat Support Care. 2007 Jun;5(2):161-6. Review.PMID: 17578067 [PubMed - indexed for MEDLINE]Related articles

    4.

    Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

    Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.

    J Support Oncol. 2009 Jan-Feb;7(1):39-46.PMID: 19278178 [PubMed - indexed for MEDLINE]Related articles

    5.

    Incidence, prevalence, and management of opioid bowel dysfunction.

    Pappagallo M.

    Am J Surg. 2001 Nov;182(5A Suppl):11S-18S. Review.PMID: 11755892 [PubMed - indexed for MEDLINE]Related articles

    6.

    Methylnaltrexone for opioid-induced constipation.

    Belavic JM.

    Nurse Pract. 2009 Mar;34(3):6-7. No abstract available. PMID: 19240629 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

    Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

    Curr Med Res Opin. 2008 Dec;24(12):3503-12.PMID: 19032132 [PubMed - indexed for MEDLINE]Related articles

    8.

    Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.

    Reimer K, Hopp M, Zenz M, Maier C, Holzer P, Mikus G, Bosse B, Smith K, Buschmann-Kramm C, Leyendecker P.

    Pharmacology. 2009;83(1):10-7. Epub 2008 Oct 28. Review.PMID: 18957874 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Treament of morphine-induced constipation with oral naloxone]

    Latasch L, Zimmermann M, Eberhardt B, Jurna I.

    Anaesthesist. 1997 Mar;46(3):191-4. German. PMID: 9163262 [PubMed - indexed for MEDLINE]Related articles

    10.

    Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.

    Arpino PA, Thompson BT.

    J Clin Pharm Ther. 2009 Apr;34(2):171-5.PMID: 19250137 [PubMed - indexed for MEDLINE]Related articles

    11.

    Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

    Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ.

    J Pain Symptom Manage. 2008 May;35(5):458-68.PMID: 18440447 [PubMed - indexed for MEDLINE]Related articles

    12.

    Oral naloxone reverses opioid-associated constipation.

    Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K.

    Pain. 2000 Jan;84(1):105-9.PMID: 10601678 [PubMed - indexed for MEDLINE]Related articles

    13.

    Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

    Yuan CS, Foss JF, O'Connor M, Osinski J, Karrison T, Moss J, Roizen MF.

    JAMA. 2000 Jan 19;283(3):367-72.PMID: 10647800 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit.

    Tofil NM, Benner KW, Faro SJ, Winkler MK.

    Pediatr Crit Care Med. 2006 May;7(3):252-4.PMID: 16575353 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation]

    Chappell D, Conzen P.

    Schmerz. 2009 Oct;23(5):471-8. German. PMID: 19690895 [PubMed - in process]Related articles

    16.

    Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.

    Yuan CS.

    J Support Oncol. 2004 Mar-Apr;2(2):111-7; discussion 119-22. Review.PMID: 15328815 [PubMed - indexed for MEDLINE]Related articles

    17.

    Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.

    Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B, Spohr I, Reimer K.

    J Opioid Manag. 2009 May-Jun;5(3):145-51. Review.PMID: 19662924 [PubMed - indexed for MEDLINE]Related articles

    18.

    A review of the potential role of methylnaltrexone in opioid bowel dysfunction.

    Foss JF.

    Am J Surg. 2001 Nov;182(5A Suppl):19S-26S. Review.PMID: 11755893 [PubMed - indexed for MEDLINE]Related articles

    19.

    Methylnaltrexone: the answer to opioid-induced constipation?

    Cannom RR, Mason RJ.

    Expert Opin Pharmacother. 2009 Apr;10(6):1039-45. Review.PMID: 19364251 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.

    Yuan CS, Foss JF, O'Connor M, Osinski J, Roizen MF, Moss J.

    Pain. 1999 Dec;83(3):631-5.PMID: 10568873 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data